Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4 USD | +0.00% | +5.98% | +15.94% |
May. 22 | Xenetic Biosciences, Inc. Announces Management Resignations | CI |
May. 22 | Xenetic Biosciences, Inc. Announces Chief Executive Officer Changes | CI |
Sales 2024 * | 1.76M 2.25M | Sales 2025 * | 1.44M 1.84M | Capitalization | 4.82M 6.16M |
---|---|---|---|---|---|
Net income 2024 * | -4M -5.11M | Net income 2025 * | -7M -8.94M | EV / Sales 2024 * | 2.74 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.35 x |
P/E ratio 2024 * |
-4.17
x | P/E ratio 2025 * |
-5.48
x | Employees | 4 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.81% |
1 day | -1.30% | ||
1 week | +4.71% | ||
Current month | +2.56% | ||
1 month | -6.32% | ||
3 months | -1.23% | ||
6 months | +13.31% | ||
Current year | +15.94% |
Managers | Title | Age | Since |
---|---|---|---|
James Parslow
CEO | Chief Executive Officer | 59 | 17-04-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Moshe Mizrahy
BRD | Director/Board Member | 71 | - |
Adam Logal
CHM | Chairman | 46 | 17-08-13 |
Dmitriy Genkin
BRD | Director/Board Member | 56 | 03-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 4 | +0.00% | 3 608 |
24-06-04 | 4 | -1.30% | 2,919 |
24-06-03 | 4.053 | +3.91% | 3,465 |
24-05-31 | 3.9 | +4.28% | 902 |
24-05-30 | 3.74 | -0.91% | 2,023 |
Delayed Quote Nasdaq, June 04, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.94% | 6.16M | |
+16.73% | 123B | |
+13.04% | 107B | |
-5.80% | 24.01B | |
+2.15% | 22.59B | |
-10.09% | 18.16B | |
-40.52% | 16.84B | |
-14.00% | 16.23B | |
+1.18% | 13.43B | |
+24.18% | 11.32B |
- Stock Market
- Equities
- XBIO Stock